Ann: Appendix 3A Consolidation of Capital-MNQ.AX, page-24

RAP was (still is) a monster, i regret not holding on for slightly longer.

There are definitely similarities between the two companies in terms of the overall approach to be classed as a medical device, and the process / news flow that comes with this.

RAP holders, or people familiar with the story, should easily be able to migrate across to ePAT and understand what the company is trying to achieve. It's a pretty straight forward conversion, just a different market.

It's mind blowing that worldwide, 47.5 million people have dementia with 7.7 million new cases every year. I remeber reading it's going to almost triple to 130m by 2050? and the total worldwide cost of dementia will be about $2 trillion i believe.

And @Master Burrows i always get my fill mate...